571
Participants
Start Date
May 17, 2013
Primary Completion Date
January 24, 2016
Study Completion Date
April 24, 2025
Tremelimumab
Tremelimumab is to be administered as an IV solution, followed by observation.
Placebo
Placebo is to be administered as an IV solution, followed by observation.
Research Site, Törökbálint
Research Site, Saint Leonards
Research Site, Copenhagen
Research Site, Gosford
Research Site, Waratah
Research Site, Edegem
Research Site, Leuven
Research Site, Heidelberg
Research Site, Box Hill
Research Site, East Bentleigh
Research Site, Gyöngyös - Mátraháza
Research Site, Chermside
Research Site, Auchenflower
Research Site, Adelaide
Research Site, Nedlands
Research Site, Kraaifontein
Research Site, Ghent
Research Site, Orbassano
Research Site, Candiolo
Research Site, New York
Research Site, Berlin
Research Site, Caen
Research Site, Rochester
Research Site, Alessandria
Research Site, Genova
Research Site, Philadelphia
Research Site, Newark
Research Site, Donostia / San Sebastian
Research Site, Rozzano
Research Site, Milan
Research Site, Hamburg
Research Site, Baltimore
Research Site, Baltimore
Research Site, Lund
Research Site, Großhansdorf
Research Site, Lübeck
Research Site, Bergamo
Research Site, Durham
Research Site, Madrid
Research Site, Augusta
Research Site, Toulouse
Research Site, Aviano
Research Site, Tampa
Research Site, Rennes
Research Site, Padua
Research Site, Bologna
Research Site, Seville
Research Site, Canton
Research Site, Meldola
Research Site, Siena
Research Site, Minneapolis
Research Site, Jeonnam
Research Site, Linköping
Research Site, Hemer
Research Site, Lille
Research Site, Chicago
Research Site, Peoria
Research Site, Le Mans
Research Site, Esslingen a.N.
Research Site, Löwenstein
Research Site, Dallas
Research Site, Karlsruhe
Research Site, Houston
Research Site, Freiburg im Breisgau
Research Site, Gauting
Research Site, Beersheba
Research Site, Scottsdale
Research Site, Los Angeles
Research Site, Santa Monica
Research Site, La Jolla
Research Site, San Francisco
Research Site, Villejuif
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Craiova
Research Site, Nizhny Novgorod
Research Site, New Haven
Research Site, Toronto
Research Site, Sainte-Foy
Research Site, Nice
Research Site, Breda
Research Site, Eindhoven
Research Site, Rotterdam
Research Site, Gdansk
Research Site, Poznan
Research Site, Szczecin
Research Site, Warsaw
Research Site, Pretoria
Research Site, Pretoria
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Sabadell (Barcelona)
Research Site, Umeå
Research Site, Leeds
Research Site, Leicester
Research Site, London
Research Site, London
Research Site, Maidstone
Research Site, Manchester
Research Site, Metropolitan Borough of Wirral
Research Site, Plymouth
Research Site, Southampton
Lead Sponsor
MedImmune LLC
INDUSTRY